Markets:

Overview

News

Currencies

International

Treasuries

Harmony Biosciences Holdings, Inc. - Common Stock (NQ:HRMY)

35.29 UNCHANGED

Streaming Delayed Price Updated: 1:00 PM EST, Nov 28, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Harmony Biosciences Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Where Harmony Biosciences Stands With Analysts ↗

October 14, 2022

Analysts have provided the following ratings for Harmony Biosciences (NASDAQ:HRMY) within the last quarter:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2022 ↗

October 14, 2022

Upgrades

Via Benzinga

Domino's Pizza To Rally 20%? Here Are 5 Other Price Target Changes For Friday ↗

October 14, 2022

Wedbush raised Domino's Pizza, Inc. (NYSE: DPZ) price target from $370 to $400. Wedbush analyst Nick Setyan maintained an Outperform rating on the stock. Domino's shares rose 10.4% to close at $333.26...

Via Benzinga

6 Analysts Have This to Say About Harmony Biosciences ↗

August 03, 2022

Harmony Biosciences (NASDAQ:HRMY) has observed the following analyst ratings within the last quarter:

Via Benzinga

Harmony Biosciences: Q1 Earnings Insights ↗

May 03, 2022

Harmony Biosciences (NASDAQ:HRMY) reported its Q1 earnings results on Tuesday, May 3, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

Stock Market Rally Mixed As Oil Prices Fall, Job Growth Hot: Weekly Review ↗

August 05, 2022

The Nasdaq and small caps rose while the S&P 500 is hitting resistance.

Via Investor's Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2022 ↗

August 03, 2022

Via Benzinga

Harmony Biosciences Makes Leap Out Of Buy Zone After Narcolepsy Drug Drives Beat ↗

August 02, 2022

Shares surged well above the 5% chase zone in early action Tuesday.

Via Investor's Business Daily

Harmony Biosciences: Q2 Earnings Insights ↗

August 02, 2022

Harmony Biosciences (NASDAQ:HRMY) reported its Q2 earnings results on Tuesday, August 2, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 02, 2022

Via Benzinga

Preview: Harmony Biosciences's Earnings ↗

August 01, 2022

Harmony Biosciences (NASDAQ:HRMY) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that Harmony...

Via Benzinga

EXCLUSIVE: Has Biotech Bottomed? NYSE Executive Floor Director Says Biogen And These 3 Stocks Look Poised To Outperform ↗

June 30, 2022

Markets continue to trend lower amid rising inflation and Fed uncertainty, but one New York Stock Exchange floor director says the bottom may be in for a couple of beaten-down sectors.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2022 ↗

July 13, 2022

Upgrades

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2022 ↗

July 07, 2022

Upgrades

Via Benzinga

Corcept Stock Near Buy Point; Strength Rating Jumps To 91 ↗

June 23, 2022

The new 91 RS Rating means that Corcept stock has outperformed 90% of all other stocks over the past year.

Via Investor's Business Daily

7 No-Brainer Biotech Stocks to Add to Your Buy List ↗

June 09, 2022

With the broader markets grumbling, investors should consider biotech stocks to buy for their permanently relevant profile.

Via InvestorPlace

80 Biggest Movers From Yesterday ↗

May 04, 2022

Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 93.1% to close at $6.45 on Tuesday on above-average volume. XORTX Therapeutics Inc. (NASDAQ: XRTX) gained 59.1% to...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 03, 2022

Via Benzinga

Harmony Biosciences Q1 2022 Earnings Conference Call On May 3, 2022 At 08:30 AM ET ↗

April 21, 2022

Harmony Biosciences (NASDAQ:HRMY) will host a conference call at 08:30 AM ET on May 3, 2022, to discuss Q1 2022 earnings results.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2022 ↗

April 14, 2022

Upgrades

Via Benzinga

24 Biggest Movers From Yesterday ↗

April 13, 2022

Gainers Vertical Aerospace Ltd. (NYSE: EVTL) Shares hiked 30.93% to close at $9.82 on Tuesday after Deutsche Bank initiated coverage of the stock. Peabody Energy Corporation (...

Via Benzinga

Bristol Myers, Eli Lilly And 2 Others Prove You Can Still Make Money In Medical Stocks ↗

March 11, 2022

These four medical stocks are outperforming the lousy market for health care investors.

Via Investor's Business Daily

Harmony Biosciences: Q4 Earnings Insights ↗

February 28, 2022

Harmony Biosciences (NASDAQ:HRMY) reported its Q4 earnings results on Monday, February 28, 2022 at 07:30 AM. Here's what investors need to know about the announcement....

Via Benzinga

3 Desirable Drug Stocks With Very Promising Pipelines ↗

February 16, 2022

Drug makers with superb pipelines are likely to deliver great returns for long-term investors. Here are three drug stocks to consider.

Via InvestorPlace

Top Buzzing Stocks For 2022 ↗

January 25, 2022

Before making investment decisions, investors like me seek valuable insight on which sectors and/or which stocks will be giving high returns. Let’s have a broad look at what happened in 2021 and what’s...

Via Talk Markets

Datadog, Applied Materials Lead Five Stocks Near Buy Points For The New Year ↗

January 01, 2022

Your stocks to watch as 2022 starts include Datadog and chip Applied Materials.

Via Investor's Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2021 ↗

December 01, 2021

Upgrades Goldman Sachs upgraded the previous rating for Grupo Aeroportuario del Sureste SAB de CV

Via Benzinga

Harmony Biosciences Holdings, Inc. (HRMY) Q3 2021 Earnings Call Transcript ↗

November 09, 2021

HRMY earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Benzinga's Top Ratings Upgrades, Downgrades For November 4, 2021 ↗

November 04, 2021

Upgrades According to B. Riley Securities, the prior rating for Monroe Capital Corp (NASDAQ:

Via Benzinga

Leading the Charge to Develop the First Orexin-Targeted Therapy to Address Narcolepsy at its Root Cause ↗

October 20, 2021

Photo by MART PRODUCTION from Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Harmony Biosciences Holdings, Inc. - Common Stock (NQ:HRMY)

All News about Harmony Biosciences Holdings, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today